Rare diseases
Investigational molecules
Locations
Back to Spain38 clinical trials in Alzira, Spain. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)Phase 3 Study of Pitolisant for Excessive Daytime Sleepiness in Narcolepsy Patients
SpainEfficacy and Safety of ALKS 2680 and Alixorexton in Adults with Narcolepsy Type 1
SpainPhase 3 Randomized, Double‑Blind, Placebo‑Controlled Study of ALKS 2680 for Excessive Daytime Sleepiness in Adults with Narcolepsy Type 2
SpainPhase 3 Randomized Study of ALKS 2680 for Excessive Daytime Sleepiness in Adults with Narcolepsy Type 1
SpainStudy on the Long-term Safety of TAK-861 for Patients with Narcolepsy Type 1
SpainPhase 3 Randomized Placebo‑Controlled Study of Efgartigimod Alfa in Adults with Graves’ Disease Inadequately Controlled by Antithyroid Drugs
SpainA study to evaluate the efficacy and safety of eloralintide in adults with obesity or overweight and type 2 diabetes
SpainA study to evaluate the efficacy and safety of depemokimab and salbutamol sulfate in patients with chronic obstructive pulmonary disease and type 2 inflammation.
SpainA study to evaluate the effect of orforglipron on cardiovascular health in adults with atherosclerotic cardiovascular disease and/or chronic kidney disease
SpainA Study of Depemokimab Compared to Placebo in Adults with Chronic Obstructive Pulmonary Disease and Type 2 Inflammation
SpainStudy of Debio 4126, a new octreotide formulation, compared to placebo in patients with acromegaly who were previously treated with somatostatin analogs
SpainLong-Term Study on the Safety and Effects of ALKS 2680 for Patients with Narcolepsy Type 1 and Type 2
SpainThe busiest research cities in the country
What the registry says about research in the country
Innovative trials exploring treatments for Type 2 Diabetes and cardiovascular conditions, including studies of novel therapies like tirzepatide and orforglipron compared to established treatments. Research focuses on preventing major cardiovascular events and managing metabolic disorders.
Studies aim to improve patient outcomes in metabolic disorders while addressing cardiovascular risks.
Comprehensive research in bladder cancer and breast cancer treatments, investigating targeted therapies and innovative approaches. Studies include evaluation of maintenance therapies for urothelial cancer and novel treatments for hormone receptor-positive breast cancer.
Focus on personalized treatment approaches and targeted therapies for various cancer types.
Studies addressing narcolepsy and sleep disorders, along with research into vitamin D deficiency and menopausal symptoms. Trials evaluate new therapeutic options for sleep disturbances and hormone-related conditions.
Research aims to improve quality of life for patients with neurological and endocrine conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
